Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.
November 9, 2023
November 8, 2023
November 6, 2023
December 4, 2023 4:58 PM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.